10-Q: Q3 2024 Earnings Report

SECNov 4 06:04 ET · Announcements

Medera Announces Publication Of Study Utilizing Machine Learning To Enhance Next-Generation Drug Screening With Human Mini-Heart Technology

BenzingaOct 31 08:07 ET

Express News | Medera Announces Completion of Cohort a and Initiation of Dosing in Cohort B of Music-Hfpef, a Phase 1/2a Clinical Trial Evaluating First-in-Human Gene Therapy Srd-002 for Heart Failure With Preserved Ejection Fraction

ReutersOct 24 08:00 ET

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Keen Vision Acquisition Corp. Merger

newsfileSep 13 10:51 ET

Keen Vision Acquisition, Medera to Merge

MT NewswiresSep 5 09:22 ET

Cardiovascular pharmaceutical company Medera plans to go public in the United States through a reverse merger, with a valuation exceeding $0.6 billion.

Medera Inc. has reached an agreement with special purpose acquisition company Keen Vision Acquisition Corp. to go public on Nasdaq through a merger.

Zhitong FinanceSep 5 08:16 ET